Micro-RNA Sequencing and Assay Market Growth Analysis, Trends Insights, Key Drivers, Competitive Landscape and Regional Analysis

QY Research has recently published a research report titled, "Global Micro-RNA Sequencing and Assay Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", assessing various factors impacting its trajectory. The research study offers deep evaluation of the global Micro-RNA Sequencing and Assay market and helps market participants to gain a strong foothold in the industry. It sheds light on critical market dynamics such as drivers, restraints, trends, and opportunities to help businesses prepare for any challenges ahead in time. It provides regional analysis of the global Micro-RNA Sequencing and Assay market to unveil key opportunities available in different parts of the world. The competitive landscape is broadly assessed along with company profiling of leading players operating in the global Micro-RNA Sequencing and Assay market. The report provides detailed statistics and accurate market figures, viz. market share, CAGR, gross margin, and those related to revenue, production, consumption, and sales.

The global market for Micro-RNA Sequencing and Assay was estimated to be worth US$ 267 million in 2024 and is forecast to a readjusted size of US$ 508 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.qyresearch.in/request-sample/medical-care-micro-rna-sequencing-and-assay-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

The report has been compiled with the use of latest primary and secondary research methodologies. Our sources are reliable and trustworthy - so you don't have to worry about the authenticity and accuracy of this research study. We have made use of qualitative and quantitative analysis to present to you an all-inclusive, all-encompassing research study on the global Micro-RNA Sequencing and Assay market. The report also includes SWOT analysis, PESTLE analysis, and Porter's Five Forces Model analysis to offer you a complete and comprehensive study on crucial aspects of the global Micro-RNA Sequencing and Assay market.

Market drivers primarily include the following:

Technological advancements: Breakthroughs in single-molecule sequencing, long-read technologies, and AI analysis algorithms have significantly improved the sensitivity and specificity of miRNA detection. For example, NIPSS technology can simultaneously identify miRNA sequences and methylation modifications, providing a new tool for epigenetic research. AI-driven target gene prediction models (such as DeepMirTar) have increased prediction accuracy to over 90%, accelerating the transition from data to application.

Clinical demand: Demand for non-coding RNA markers is surging for early cancer screening, neurodegenerative disease diagnosis, and drug development. For example, the miRNA-based GASTROClear test kit for gastric cancer has been approved in Singapore and the EU, with domestic market launch expected by the end of 2025. For Alzheimer's disease screening, miRNA marker detection can provide early warning of pathological changes 5-8 years in advance, filling a gap in traditional imaging testing.

Policy and capital drivers: Tightening regulatory policies in the global genetic testing market are driving the industry towards standardization and regularization. For example, the FDA's increased oversight of LDTs ​​(laboratory-developed tests) is prompting companies to strengthen clinical validation and multicenter research. At the same time, capital is shifting toward early diagnostics and companion diagnostics. Global miRNA-related financing is expected to exceed $1.5 billion in 2024, with a focus on supporting cutting-edge technologies such as single-molecule sequencing and liquid biopsies.

Leading players of the global Micro-RNA Sequencing and Assay market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Micro-RNA Sequencing and Assay market. Furthermore, the report offers two separate market forecasts - one for the production side and another for the consumption side of the global Micro-RNA Sequencing and Assay market. It also provides useful recommendations for new as well as established players of the global Micro-RNA Sequencing and Assay market.

Key Players Mentioned in the Global Micro-RNA Sequencing and Assay Market Research Report:

Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB
Partek Flow
Mgi Tech Co. Ltd.

Market Segments

Our market analysts are experts in deeply segmenting the global Micro-RNA Sequencing and Assay market and thoroughly evaluating the growth potential of each and every segment studied in the report. Right at the beginning of the research study, the segments are compared on the basis of consumption and growth rate for a review period of nine years. The segmentation study included in the report offers a brilliant analysis of the global Micro-RNA Sequencing and Assay market, taking into consideration the market potential of different segments studied. It assists market participants to focus on high-growth areas of the global Micro-RNA Sequencing and Assay market and plan powerful business tactics to secure a position of strength in the industry.

Details of Micro-RNA Sequencing and Assay Market Segmentation: -

Segment by Type:

Sequencing by Synthesis
Sequencing by Nanopore
Ion Semiconductor Sequencing

Segment by Application:

Research Institute
Academia
CRO

All of the segments studied in the research study are analyzed on the basis of BPS, market share, revenue, and other important factors. Our research study shows how different segments are contributing to the growth of the global Micro-RNA Sequencing and Assay market. It also provides information on key trends related to the segments included in the report. This helps market players to concentrate on high-growth areas of the global Micro-RNA Sequencing and Assay market. The research study also offers separate analysis on the segments on the basis of absolute dollar opportunity.

Segment by Region

North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

How can the research study help your business?

(1) The information presented in the Micro-RNA Sequencing and Assay report helps your decision makers to become prudent and make the best business choices.

(2) The report enables you to see the future of the global Micro-RNA Sequencing and Assay market and accordingly take decisions that will be in the best interest of your business.

(3) It offers you a forward-looking perspective of the global Micro-RNA Sequencing and Assay market drivers and how you can secure significant market gains in the near future.

(4) It provides SWOT analysis of the global Micro-RNA Sequencing and Assay market along with useful graphics and detailed statistics providing quick information about the market's overall progress throughout the forecast period.

(5) It also assesses the changing competitive dynamics of the global Micro-RNA Sequencing and Assay market using pin-point evaluation.

Request Pre-Order Enquiry or Customized Research on This Report: https://www.qyresearch.in/pre-order-inquiry/medical-care-micro-rna-sequencing-and-assay-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Table of Contents

1 Market Overview
1.1 Micro-RNA Sequencing and Assay Product Introduction
1.2 Global Micro-RNA Sequencing and Assay Market Size Forecast (2020-2031)
1.3 Micro-RNA Sequencing and Assay Market Trends & Drivers
1.3.1 Micro-RNA Sequencing and Assay Industry Trends
1.3.2 Micro-RNA Sequencing and Assay Market Drivers & Opportunity
1.3.3 Micro-RNA Sequencing and Assay Market Challenges
1.3.4 Micro-RNA Sequencing and Assay Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Micro-RNA Sequencing and Assay Players Revenue Ranking (2024)
2.2 Global Micro-RNA Sequencing and Assay Revenue by Company (2020-2025)
2.3 Key Companies Micro-RNA Sequencing and Assay Manufacturing Base Distribution and Headquarters
2.4 Key Companies Micro-RNA Sequencing and Assay Product Offered
2.5 Key Companies Time to Begin Mass Production of Micro-RNA Sequencing and Assay
2.6 Micro-RNA Sequencing and Assay Market Competitive Analysis
2.6.1 Micro-RNA Sequencing and Assay Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Micro-RNA Sequencing and Assay Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Micro-RNA Sequencing and Assay as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sequencing by Synthesis
3.1.2 Sequencing by Nanopore
3.1.3 Ion Semiconductor Sequencing
3.2 Global Micro-RNA Sequencing and Assay Sales Value by Type
3.2.1 Global Micro-RNA Sequencing and Assay Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Micro-RNA Sequencing and Assay Sales Value, by Type (2020-2031)
3.2.3 Global Micro-RNA Sequencing and Assay Sales Value, by Type (%) (2020-2031)
4 Segmentation by Product Forms
4.1 Introduction by Product Forms
4.1.1 Reagent Kits
4.1.2 Instruments
4.1.3 Analysis Software
4.2 Global Micro-RNA Sequencing and Assay Sales Value by Product Forms
4.2.1 Global Micro-RNA Sequencing and Assay Sales Value by Product Forms (2020 VS 2024 VS 2031)
4.2.2 Global Micro-RNA Sequencing and Assay Sales Value, by Product Forms (2020-2031)
4.2.3 Global Micro-RNA Sequencing and Assay Sales Value, by Product Forms (%) (2020-2031)
5 Segmentation by Technology
5.1 Introduction by Technology
5.1.1 Two-Step Ligation Method
5.1.2 NIPSS Single-Molecule Sequencing
5.1.3 UMI Tagging
5.1.4 Other
5.2 Global Micro-RNA Sequencing and Assay Sales Value by Technology
5.2.1 Global Micro-RNA Sequencing and Assay Sales Value by Technology (2020 VS 2024 VS 2031)
5.2.2 Global Micro-RNA Sequencing and Assay Sales Value, by Technology (2020-2031)
5.2.3 Global Micro-RNA Sequencing and Assay Sales Value, by Technology (%) (2020-2031)
6 Segmentation by Application
6.1 Introduction by Application
6.1.1 Research Institute
6.1.2 Academia
6.1.3 CRO
6.2 Global Micro-RNA Sequencing and Assay Sales Value by Application
6.2.1 Global Micro-RNA Sequencing and Assay Sales Value by Application (2020 VS 2024 VS 2031)
6.2.2 Global Micro-RNA Sequencing and Assay Sales Value, by Application (2020-2031)
6.2.3 Global Micro-RNA Sequencing and Assay Sales Value, by Application (%) (2020-2031)
7 Segmentation by Region
7.1 Global Micro-RNA Sequencing and Assay Sales Value by Region
7.1.1 Global Micro-RNA Sequencing and Assay Sales Value by Region: 2020 VS 2024 VS 2031
7.1.2 Global Micro-RNA Sequencing and Assay Sales Value by Region (2020-2025)
7.1.3 Global Micro-RNA Sequencing and Assay Sales Value by Region (2026-2031)
7.1.4 Global Micro-RNA Sequencing and Assay Sales Value by Region (%), (2020-2031)
7.2 North America
7.2.1 North America Micro-RNA Sequencing and Assay Sales Value, 2020-2031
7.2.2 North America Micro-RNA Sequencing and Assay Sales Value by Country (%), 2024 VS 2031
7.3 Europe
7.3.1 Europe Micro-RNA Sequencing and Assay Sales Value, 2020-2031
7.3.2 Europe Micro-RNA Sequencing and Assay Sales Value by Country (%), 2024 VS 2031
7.4 Asia Pacific
7.4.1 Asia Pacific Micro-RNA Sequencing and Assay Sales Value, 2020-2031
7.4.2 Asia Pacific Micro-RNA Sequencing and Assay Sales Value by Region (%), 2024 VS 2031
7.5 South America
7.5.1 South America Micro-RNA Sequencing and Assay Sales Value, 2020-2031
7.5.2 South America Micro-RNA Sequencing and Assay Sales Value by Country (%), 2024 VS 2031
7.6 Middle East & Africa
7.6.1 Middle East & Africa Micro-RNA Sequencing and Assay Sales Value, 2020-2031
7.6.2 Middle East & Africa Micro-RNA Sequencing and Assay Sales Value by Country (%), 2024 VS 2031
8 Segmentation by Key Countries/Regions
8.1 Key Countries/Regions Micro-RNA Sequencing and Assay Sales Value Growth Trends, 2020 VS 2024 VS 2031
8.2 Key Countries/Regions Micro-RNA Sequencing and Assay Sales Value, 2020-2031
8.3 United States
8.3.1 United States Micro-RNA Sequencing and Assay Sales Value, 2020-2031
8.3.2 United States Micro-RNA Sequencing and Assay Sales Value by Type (%), 2024 VS 2031
8.3.3 United States Micro-RNA Sequencing and Assay Sales Value by Application, 2024 VS 2031
8.4 Europe
8.4.1 Europe Micro-RNA Sequencing and Assay Sales Value, 2020-2031
8.4.2 Europe Micro-RNA Sequencing and Assay Sales Value by Type (%), 2024 VS 2031
8.4.3 Europe Micro-RNA Sequencing and Assay Sales Value by Application, 2024 VS 2031
8.5 China
8.5.1 China Micro-RNA Sequencing and Assay Sales Value, 2020-2031
8.5.2 China Micro-RNA Sequencing and Assay Sales Value by Type (%), 2024 VS 2031
8.5.3 China Micro-RNA Sequencing and Assay Sales Value by Application, 2024 VS 2031
8.6 Japan
8.6.1 Japan Micro-RNA Sequencing and Assay Sales Value, 2020-2031
8.6.2 Japan Micro-RNA Sequencing and Assay Sales Value by Type (%), 2024 VS 2031
8.6.3 Japan Micro-RNA Sequencing and Assay Sales Value by Application, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Micro-RNA Sequencing and Assay Sales Value, 2020-2031
8.7.2 South Korea Micro-RNA Sequencing and Assay Sales Value by Type (%), 2024 VS 2031
8.7.3 South Korea Micro-RNA Sequencing and Assay Sales Value by Application, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Micro-RNA Sequencing and Assay Sales Value, 2020-2031
8.8.2 Southeast Asia Micro-RNA Sequencing and Assay Sales Value by Type (%), 2024 VS 2031
8.8.3 Southeast Asia Micro-RNA Sequencing and Assay Sales Value by Application, 2024 VS 2031
8.9 India
8.9.1 India Micro-RNA Sequencing and Assay Sales Value, 2020-2031
8.9.2 India Micro-RNA Sequencing and Assay Sales Value by Type (%), 2024 VS 2031
8.9.3 India Micro-RNA Sequencing and Assay Sales Value by Application, 2024 VS 2031
9 Company Profiles
9.1 Illumina
9.1.1 Illumina Profile
9.1.2 Illumina Main Business
9.1.3 Illumina Micro-RNA Sequencing and Assay Products, Services and Solutions
9.1.4 Illumina Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2020-2025)
9.1.5 Illumina Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Profile
9.2.2 Thermo Fisher Scientific Main Business
9.2.3 Thermo Fisher Scientific Micro-RNA Sequencing and Assay Products, Services and Solutions
9.2.4 Thermo Fisher Scientific Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2020-2025)
9.2.5 Thermo Fisher Scientific Recent Developments
9.3 QIAGEN
9.3.1 QIAGEN Profile
9.3.2 QIAGEN Main Business
9.3.3 QIAGEN Micro-RNA Sequencing and Assay Products, Services and Solutions
9.3.4 QIAGEN Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2020-2025)
9.3.5 QIAGEN Recent Developments
9.4 Takara Bio
9.4.1 Takara Bio Profile
9.4.2 Takara Bio Main Business
9.4.3 Takara Bio Micro-RNA Sequencing and Assay Products, Services and Solutions
9.4.4 Takara Bio Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2020-2025)
9.4.5 Takara Bio Recent Developments
9.5 NEB
9.5.1 NEB Profile
9.5.2 NEB Main Business
9.5.3 NEB Micro-RNA Sequencing and Assay Products, Services and Solutions
9.5.4 NEB Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2020-2025)
9.5.5 NEB Recent Developments
9.6 Partek Flow
9.6.1 Partek Flow Profile
9.6.2 Partek Flow Main Business
9.6.3 Partek Flow Micro-RNA Sequencing and Assay Products, Services and Solutions
9.6.4 Partek Flow Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2020-2025)
9.6.5 Partek Flow Recent Developments
9.7 Mgi Tech Co.,Ltd.
9.7.1 Mgi Tech Co.,Ltd. Profile
9.7.2 Mgi Tech Co.,Ltd. Main Business
9.7.3 Mgi Tech Co.,Ltd. Micro-RNA Sequencing and Assay Products, Services and Solutions
9.7.4 Mgi Tech Co.,Ltd. Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2020-2025)
9.7.5 Mgi Tech Co.,Ltd. Recent Developments
10 Industry Chain Analysis
10.1 Micro-RNA Sequencing and Assay Industrial Chain
10.2 Micro-RNA Sequencing and Assay Upstream Analysis
10.2.1 Key Raw Materials
10.2.2 Raw Materials Key Suppliers
10.2.3 Manufacturing Cost Structure
10.3 Midstream Analysis
10.4 Downstream Analysis (Customers Analysis)
10.5 Sales Model and Sales Channels
10.5.1 Micro-RNA Sequencing and Assay Sales Model
10.5.2 Sales Channel
10.5.3 Micro-RNA Sequencing and Assay Distributors
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

About US:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

Contact US

Ankit Jain - Director, Global Digital Marketing

QY Research, INC.
India Office -
315Work Avenue, Raheja Woods, Kalyani Nagar,
Pune, Maharashtra 411006, India
Web - https://www.qyresearch.in
Email- ankit@qyresearch.com

This release was published on openPR.